161 related articles for article (PubMed ID: 37625993)
1. Bacterial ghost cell based bivalent candidate vaccine against Salmonella Typhi and Salmonella Paratyphi A: A prophylactic study in BALB/c mice.
Halder P; Maiti S; Banerjee S; Das S; Dutta M; Dutta S; Koley H
Vaccine; 2023 Sep; 41(41):5994-6007. PubMed ID: 37625993
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever.
Howlader DR; Koley H; Sinha R; Maiti S; Bhaumik U; Mukherjee P; Dutta S
PLoS One; 2018; 13(9):e0203631. PubMed ID: 30216367
[TBL] [Abstract][Full Text] [Related]
3. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
4. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
Das S; Chowdhury R; Pal A; Okamoto K; Das S
Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
6. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
Wahid R; Fresnay S; Levine MM; Sztein MB
Mucosal Immunol; 2015 Nov; 8(6):1349-59. PubMed ID: 25872480
[TBL] [Abstract][Full Text] [Related]
7. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
9. Bivalent non-typhoidal Salmonella outer membrane vesicles immunized mice sera confer passive protection against gastroenteritis in a suckling mice model.
Maiti S; Howlader DR; Halder P; Bhaumik U; Dutta M; Dutta S; Koley H
Vaccine; 2021 Jan; 39(2):380-393. PubMed ID: 33303233
[TBL] [Abstract][Full Text] [Related]
10. A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses.
Won G; Kim B; Lee JH
Vaccine; 2017 Jun; 35(25):3333-3341. PubMed ID: 28495314
[TBL] [Abstract][Full Text] [Related]
11. A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever.
Howlader DR; Koley H; Maiti S; Bhaumik U; Mukherjee P; Dutta S
Vaccine; 2017 Nov; 35(47):6359-6366. PubMed ID: 29031693
[TBL] [Abstract][Full Text] [Related]
12. Status of paratyphoid fever vaccine research and development.
Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
[TBL] [Abstract][Full Text] [Related]
13. Vaccine value profile for Salmonella enterica serovar Paratyphi A.
Martin LB; Khanam F; Qadri F; Khalil I; Sikorski MJ; Baker S
Vaccine; 2023 Nov; 41 Suppl 2():S114-S133. PubMed ID: 37951691
[TBL] [Abstract][Full Text] [Related]
14. Multi-epitope DnaK peptide vaccine accords protection against lethal S. typhimurium challenge: Elicits both cell mediated immunity and long-lasting serum-neutralizing antibody titers.
Verma S; Singh K; Bansal A
Pharmacol Res; 2021 Jul; 169():105652. PubMed ID: 33975015
[TBL] [Abstract][Full Text] [Related]
15. Generation of a safety enhanced Salmonella Gallinarum ghost using antibiotic resistance free plasmid and its potential as an effective inactivated vaccine candidate against fowl typhoid.
Jawale CV; Chaudhari AA; Lee JH
Vaccine; 2014 Feb; 32(9):1093-9. PubMed ID: 24406393
[TBL] [Abstract][Full Text] [Related]
16. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
Schwartz E; Shlim DR; Eaton M; Jenks N; Houston R
Arch Intern Med; 1990 Feb; 150(2):349-51. PubMed ID: 2105702
[TBL] [Abstract][Full Text] [Related]
17. A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal
Haldar R; Dhar A; Ganguli D; Chakraborty S; Pal A; Banik G; Miyoshi SI; Das S
Front Immunol; 2023; 14():1304170. PubMed ID: 38264668
[TBL] [Abstract][Full Text] [Related]
18. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.
Wahid R; Fresnay S; Levine MM; Sztein MB
Clin Immunol; 2016 Dec; 173():87-95. PubMed ID: 27634430
[TBL] [Abstract][Full Text] [Related]
20. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
Wahid R; Simon R; Zafar SJ; Levine MM; Sztein MB
Clin Vaccine Immunol; 2012 Jun; 19(6):825-34. PubMed ID: 22492745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
